180 Life Sciences Corp. Profile Avatar - Palmy Investing

180 Life Sciences Corp.

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor ne…

Biotechnology
US, Palo Alto [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

180 Life Sciences Corp. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

180 Life Sciences Corp. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of 180 Life Sciences Corp..

If you want to see a demo, head over to the financial segments of AAPL

End of ATNF's Analysis
CIK: 1690080 CUSIP: 68236V104 ISIN: US68236V3024 LEI: - UEI: -
Secondary Listings
ATNF has no secondary listings inside our databases.